Table 1.
Male(n = 3117) | Female (n = 3336) | Total (n = 6453) | |||||||
---|---|---|---|---|---|---|---|---|---|
n | % | 95%CI | n | P | 95%CI | n | % | 95%CI | |
FH of UGI | |||||||||
First degree relative history | |||||||||
1 | 68 | 2.2 | 1.7-2.7 | 47 | 1.4 | 1.0-1.8 | 115 | 1.8 | 1.5-2.1 |
2 or more | 10 | 0.3 | 0.1-0.5 | 9 | 0.3 | 0.1-0.5 | 19 | 0.3 | 0.2-0.4 |
Total | 78 | 2.5 | 2-3 | 56 | 1.7 | 1.3-2.1 | 134 | 2.1 | 1.8-2.4 |
Second degree relative history | |||||||||
1 | 77 | 2.5 | 2-3 | 85 | 2.5 | 2-3 | 162 | 2.5 | 2.1-2.9 |
2 or more | 22 | 0.7 | 0.4-1 | 23 | 0.7 | 0.4-1 | 45 | 0.7 | 0.5-0.9 |
Total | 99 | 3.2 | 2.6-3.8 | 108 | 3.2 | 2.6-3.8 | 207 | 3.2 | 2.8-3.6 |
First or second degree relative diagnosed with UGI cancers | 177 | 5.7 | 4.9-6.5 | 164 | 4.9 | 4.2-5.6 | 341 | 5.3 | 4.8-5.8 |
FH of any cancer (except UGI) | |||||||||
First degree relative history | |||||||||
1 | 385 | 12.4 | 11.2-13.6 | 287 | 8.6 | 7.6-9.6 | 672 | 10.4 | 9.7-11.1 |
2 or more | 46 | 1.5 | 1.1-1.9 | 31 | 0.9 | 0.6-1.2 | 77 | 1.2 | 0.9-1.5 |
Total | 431 | 13.8 | 12.6-15 | 318 | 9.5 | 8.5-10.5 | 749 | 11.6 | 10.8-12.4 |
Second degree relative history | |||||||||
1 | 452 | 14.5 | 13.3-15.7 | 372 | 11.2 | 10.1-12.3 | 824 | 12.8 | 12-13.6 |
2 or more | 97 | 3.1 | 2.5-3.7 | 70 | 2.1 | 1.6-2.6 | 167 | 2.6 | 2.2-3 |
Total | 549 | 17.6 | 16.3-18.9 | 442 | 13.3 | 12.1-14.5 | 1091 | 16.9 | 16-17.8 |
First or second degree relative diagnosed with UGI cancers | 980 | 31.4 | 29.8-33 | 760 | 22.8 | 21.4-24.2 | 1840 | 28.5 | 27.4-29.6 |